Daru Lu

13.9k total citations
286 papers, 7.8k citations indexed

About

Daru Lu is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Daru Lu has authored 286 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 175 papers in Molecular Biology, 72 papers in Genetics and 60 papers in Cancer Research. Recurrent topics in Daru Lu's work include RNA modifications and cancer (31 papers), Epigenetics and DNA Methylation (27 papers) and DNA Repair Mechanisms (23 papers). Daru Lu is often cited by papers focused on RNA modifications and cancer (31 papers), Epigenetics and DNA Methylation (27 papers) and DNA Repair Mechanisms (23 papers). Daru Lu collaborates with scholars based in China, United States and Germany. Daru Lu's co-authors include Jin Li, Ji Qian, Qingyi Wei, Hongbing Shen, Hongyan Chen, Bing Su, Jia Guo, Wuli Yang, Xin Gao and Zhibin Hu and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Daru Lu

277 papers receiving 7.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daru Lu China 48 4.3k 1.7k 1.4k 964 518 286 7.8k
Tsai‐Ching Hsu Taiwan 44 3.2k 0.7× 1.3k 0.8× 1.3k 1.0× 863 0.9× 487 0.9× 238 6.7k
Liying Yan China 45 4.8k 1.1× 1.1k 0.7× 1.3k 0.9× 772 0.8× 312 0.6× 189 7.8k
María E. Figueroa United States 47 8.3k 1.9× 1.1k 0.6× 1.9k 1.4× 723 0.8× 367 0.7× 136 11.2k
Seiichi Mori Japan 46 3.9k 0.9× 1.8k 1.1× 1.5k 1.1× 2.3k 2.3× 513 1.0× 206 9.1k
Kazuo Yamamoto Japan 53 5.3k 1.2× 1.1k 0.6× 1.3k 0.9× 958 1.0× 354 0.7× 304 9.8k
Anne Ryan United States 33 5.1k 1.2× 1.3k 0.8× 645 0.5× 995 1.0× 536 1.0× 80 9.8k
Paolo Fortina United States 47 4.7k 1.1× 875 0.5× 1.9k 1.4× 1.4k 1.5× 614 1.2× 208 9.2k
Lanlan Shen United States 55 7.7k 1.8× 1.3k 0.8× 1.7k 1.2× 1.7k 1.8× 653 1.3× 131 10.6k
Agustín F. Fernández Spain 44 5.6k 1.3× 817 0.5× 2.3k 1.7× 890 0.9× 354 0.7× 117 7.4k
Peter L. Molloy Australia 41 7.7k 1.8× 2.0k 1.2× 1.6k 1.2× 899 0.9× 762 1.5× 98 9.8k

Countries citing papers authored by Daru Lu

Since Specialization
Citations

This map shows the geographic impact of Daru Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daru Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daru Lu more than expected).

Fields of papers citing papers by Daru Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daru Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daru Lu. The network helps show where Daru Lu may publish in the future.

Co-authorship network of co-authors of Daru Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Daru Lu. A scholar is included among the top collaborators of Daru Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daru Lu. Daru Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Yao, Tao Qi, Yuan Yang, et al.. (2023). A highly specific CRISPR-Cas12j nuclease enables allele-specific genome editing. Science Advances. 9(6). eabo6405–eabo6405. 35 indexed citations
3.
Gao, Peng, Zujun Fang, Danfeng Xu, et al.. (2023). Systematic evaluation of narrow‐sense validity of polygenic risk score for prostate cancer in a Chinese prostate biopsy cohort. Clinical Genetics. 103(6). 636–643.
4.
5.
Zhang, Haokun, Anning Lin, Zhen Wu, et al.. (2022). Multi-Omics Analysis in β-Thalassemia Using an HBB Gene-Knockout Human Erythroid Progenitor Cell Model. International Journal of Molecular Sciences. 23(5). 2807–2807. 8 indexed citations
6.
Zhang, Haokun, et al.. (2022). Prime Editor 3 Mediated Beta-Thalassemia Mutations of the HBB Gene in Human Erythroid Progenitor Cells. International Journal of Molecular Sciences. 23(9). 5002–5002. 9 indexed citations
7.
Hu, Ziying, Chengdong Zhang, Shuai Wang, et al.. (2021). Discovery and engineering of small SlugCas9 with broad targeting range and high specificity and activity. Nucleic Acids Research. 49(7). 4008–4019. 44 indexed citations
8.
Yu, Hongjie, Zhuqing Shi, Xiaoling Lin, et al.. (2019). Broad‐ and narrow‐sense validity performance of three polygenic risk score methods for prostate cancer risk assessment. The Prostate. 80(1). 83–87. 6 indexed citations
9.
10.
Yu, Hongjie, Zhuqing Shi, Yishuo Wu, et al.. (2019). Concept and benchmarks for assessing narrow‐sense validity of genetic risk score values. The Prostate. 79(10). 1099–1105. 14 indexed citations
11.
Wei, Feng, Xianling Guo, Haidong Huang, et al.. (2018). Polymorphism rs3819102 in thymidylate synthase and environmental factors: effects on lung cancer in Chinese population. Current Problems in Cancer. 43(1). 66–74. 6 indexed citations
12.
Shao, Minhua, Bo Jin, Yanjie Niu, et al.. (2014). Association of POLK Polymorphisms with Platinum-Based Chemotherapy Response and Severe Toxicity in Non-small Cell Lung Cancer Patients. Cell Biochemistry and Biophysics. 70(2). 1227–1237. 19 indexed citations
13.
Chen, Hongyan, et al.. (2014). Possible association between polymorphisms of VEGFR2 rs2071559 and glioma risk in Chinese population. 14(11). 1007–1012. 1 indexed citations
14.
Wu, Junjie, Yuhao Zhou, Jun Ying, et al.. (2012). Predictive Value of XRCC1 Gene Polymorphisms on Platinum-Based Chemotherapy in Advanced Non–Small Cell Lung Cancer Patients: A Systematic Review and Meta-analysis. Clinical Cancer Research. 18(14). 3972–3981. 42 indexed citations
15.
Li, Rui, Yao Zhao, Weiwei Fan, et al.. (2010). Possible association between polymorphisms of human vascular endothelial growth factor A gene and susceptibility to glioma in a Chinese population. International Journal of Cancer. 128(1). 166–175. 23 indexed citations
16.
Wu, Chen, Zhibin Hu, Dianke Yu, et al.. (2009). Genetic Variants on Chromosome 15q25 Associated with Lung Cancer Risk in Chinese Populations. Cancer Research. 69(12). 5065–5072. 114 indexed citations
17.
Miao, Ruifen, Hongliang Liu, Zhibin Hu, et al.. (2008). Tagging single nucleotide polymorphisms in MBD4 are associated with risk of lung cancer in a Chinese population. Lung Cancer. 62(3). 281–286. 13 indexed citations
18.
Chen, Bo, Yunping Hu, Taiyi Jin, et al.. (2007). The influence of metabolic gene polymorphisms on urinary 1-hydroxypyrene concentrations in Chinese coke oven workers. The Science of The Total Environment. 381(1-3). 38–46. 25 indexed citations
19.
Chen, Li, et al.. (2003). Muscle injection of rAAV/mFIX to secrete clotting factor IX corrects the hemorrhagic tendencies in hemophilia B mice. Science in China Series C Life Sciences. 46(4). 422–430. 1 indexed citations
20.
Lu, Daru, et al.. (2001). A bicistronic retroviral vector to introduce drug resistance genes into human umbilical cord blood CD34+ cells to improve combination chemotherapy tolerance.. PubMed. 114(1). 25–9. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsai‐Ching Hsu Breakdown of academic impact, for papers by Liying Yan Breakdown of academic impact, for papers by María E. Figueroa Breakdown of academic impact, for papers by Seiichi Mori Breakdown of academic impact, for papers by Kazuo Yamamoto Breakdown of academic impact, for papers by Anne Ryan Breakdown of academic impact, for papers by Paolo Fortina Breakdown of academic impact, for papers by Lanlan Shen Breakdown of academic impact, for papers by Agustín F. Fernández Breakdown of academic impact, for papers by Peter L. Molloy
Rankless by CCL
2026